Showing results (1-10 of 2) with videos related to
Sort By:
Pageof 1
Anticancer Research|May 18, 2012
A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumorsBenjamin Friday, Yvonne Lassere, Christina A Meyers, et al.Pageof 1